What is the difference between Chonluten and Vilon?

Chonluten: Tripeptide bioregulator targeting bronchial epithelial cells; normalizes gene expression in bronchial tissue; promotes epithelial regeneration Vilon: Synthetic dipeptide Lys-Glu; modulates T-cell and NK cell activity; reduces age-related immune decline; normalizes cytokine production via epigenetic gene regulation

Is Chonluten FDA approved?

Chonluten is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Vilon FDA approved?

Vilon is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Chonluten administered in research settings?

In research settings, Chonluten is typically administered via the oral or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is Vilon administered in research settings?

In research settings, Vilon is typically administered via the subcutaneous or intramuscular routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Chonluten vs Vilon

Peptide Comparison

Chonluten vs Vilon

Name: Chonluten vs Vilon — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Immune & Thymic peptides.

Chonluten

Bronchogen

RecoveryNot EvaluatedResearch Only

Half-life: Unknown

3 providers listed

Full Chonluten profile →

Vilon

Lys-Glu

LongevityNot EvaluatedResearch Only

Half-life: Unknown

3 providers listed

Full Vilon profile →

Bottom line

Chonluten and Vilon are closely matched on the structured measures we track — availability, evidence, and regulatory status are similar.

Quick Verdict

Chonluten

Vilon

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Chonluten
Oral administration option	Chonluten

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Chonluten

Vilon

Mechanism Family

Immune & Thymic

Half-life

Unknown

FDA Status

not evaluated

Admin Routes

oral, subcutaneous

subcutaneous, intramuscular

Availability

Research Only

Providers

3 listed

Avail. Notes

Russian peptide bioregulator (Glu-Asp-Lys) from Khavinson Institute. Developed for lung health. No FDA approval, no NDA or IND. Not on any FDA list. Research chemical in US.

Russian dipeptide bioregulator (Lys-Glu) from Khavinson Institute. Immunomodulatory and longevity research. Not FDA-approved. Not on any FDA list. Research chemical in US.

Research Evidence

Chonluten

Review · 2 key studies · most recent 2022

Vilon

Animal · 1 key study · dated evidence base — most recent 2002

Research Citations

Chonluten

Review2022 · International Journal of Molecular Sciences

Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers

Review2021 · Molecules

Peptide Regulation of Gene Expression: A Systematic Review

Vilon

Animal2002 · Bulletin of Experimental Biology and Medicine

Comparative study of the effects of vilon, epithalon, and cortagen on thymocyte proliferation and sphingomyel…

About Chonluten

Tripeptide bioregulator targeting bronchial epithelial cells; normalizes gene expression in bronchial tissue; promotes epithelial regeneration

Research Areas

bronchial repairlung tissue regenerationrespiratory anti-inflammatory

About Vilon

Synthetic dipeptide Lys-Glu; modulates T-cell and NK cell activity; reduces age-related immune decline; normalizes cytokine production via epigenetic gene regulation

Research Areas

immune modulationanti-agingimmune restorationlongevity

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Chonluten

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Vilon

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Chonluten

$2.95/mg

$2.50 – $3.40 range

13 vendors

View price index →Find providers →

Vilon

$2.88/mg

$2.66 – $3.01 range

12 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

Chonluten

3 listed

Browse directory →

Providers offering

Vilon

3 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Immune & Thymic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated August 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Chonluten vs Vilon — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/chonluten/vilon

https://peptidebase.io/peptides/compare/chonluten/vilon Methodology License Download JSON Download CSV